Table 5.
AUROC of clinician assessment of likelihood of skin cancer.
| Class | Biopsied lesions (95% CI) | All lesions (95% CI) |
|---|---|---|
| Lesions (N) | 396 | 583 |
| Melanoma | 90.2% (80.2–100%) | 90.3% (80.4–100%) |
| SCC | 74.0% (66.4–81.6%) | 76.9% (69.6–84.3%) |
| BCC | 85.6% (81.8–89.3%) | 90.0% (87.3–92.7%) |
| IEC | 63.6% (49.8–77.4%) | 63.6% (49.8–77.4%) |
| AK | 56.9% (49.2–64.6%) | 85.0% (79.2–90.8%) |
| Atypical | 83.2% (72.3–94%) | 85.1% (75.1–95%) |
| Benign | 67.1% (62.2–72%) | 82.1% (78.8–85.5%) |
AUROC, Area Under the Receiver Operator Characteristic Curve; SCC, Squamous Cell Carcinoma; BCC, Basal Cell Carcinoma; IEC, Intraepidermal Carcinoma; AK, Actinic keratosis; CI, Confidence Intervals.